search
Back to results

Mobile Physical Activity for Type 1 Diabetes

Primary Purpose

Type1diabetes

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mobile application
Sponsored by
Yale University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Type1diabetes

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Type 1 diabetes or other insulin deficiency diabetes

    a. Diagnosed for at least six months

  2. Lower than recommended physical activity level for at least 2 months

    a. Defined as performing sustained moderate to vigorous physical activity (20min) on less than three days per week

  3. Own a smartphone
  4. Own a continuous glucose monitor with enough supplies for 10 weeks a. When available, we will provide these to those who do not own them, in which case they will be considered to meet this criteria

Exclusion criteria:

  1. Chronic renal failure
  2. Class 3 obesity

    a. Defined as body mass index greater than 40 kg/m^2

  3. Pregnancy
  4. Cognitive impairment
  5. Inability to read and/or understand English
  6. Severe retinopathy
  7. Neuropathy or nephropathy
  8. History of arrhythmia
  9. Myocardial infarction and (or) angina in past six months
  10. Other chronic disease or physical disability that would influence treatment intervention
  11. Other chronic disease or physical disability that would preclude participation in regular physical activity

Sites / Locations

  • Yale University

Outcomes

Primary Outcome Measures

Moderate to vigorous physical activity (objective)
Minutes per day assessed by hip accelerometry
Moderate to vigorous physical activity (subjective)
Minutes per day assessed by workouts logged on mobile application

Secondary Outcome Measures

Full Information

First Posted
December 16, 2019
Last Updated
May 3, 2021
Sponsor
Yale University
search

1. Study Identification

Unique Protocol Identification Number
NCT04204733
Brief Title
Mobile Physical Activity for Type 1 Diabetes
Official Title
Mobile Approaches to Promote Physical Activity in Type 1 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
January 6, 2020 (Actual)
Primary Completion Date
November 12, 2020 (Actual)
Study Completion Date
November 12, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study is the formative observation stage of behavioral intervention development. Sedentary adults with type 1 diabetes will be given access to a mobile application that incorporates biosensor feedback, teleconsultation, and online group exercise classes. The first aim is to quantify the feasibility, acceptability, and preliminary efficacy of the application. The second aim is to evaluate predictors and mechanisms of physical activity behavior change among these adults. The possible predictors the investigators are monitoring include usage of specific application features, momentary internal factors (e.g., pre-activity fear of hypoglycemia), momentary external factors (e.g., location), and latent external factors (e.g., mental health traits). These results will be used to develop a refined mobile application utilizing the most popular application features, as well as an algorithm that uses the identified predictors of physical activity to advise adults with type 1 diabetes when to engage in physical activity (i.e., context-aware physical activity coaching) and when to make related diet and insulin adjustments.
Detailed Description
People with type 1 diabetes (T1D), which includes ~1 million American adults, have an 8-fold higher risk of mortality attributable to cardiovascular disease than those in their decade cohort. Current evidence-based T1D self-management interventions target cardiovascular risk by improving glycemic control, but do not effectively address other modifiable risk factors prevalent in T1D such as hypertension, dyslipidemia and obesity. Thus, T1D interventions that are effective for a broader range of health targets than glycemic control are urgently needed. Moderate to vigorous physical activity (MVPA) interventions could provide a novel solution, but only if they can attenuate the unique barriers to MVPA posed by T1D: 1) insufficient knowledge of insulin pharmacokinetics to self-manage and prevent unpredictable blood glucose fluctuations during MVPA; 2) fear of MVPA-induced hypoglycemia; and 3) lack of perceived social support for T1D. The present study is conducting formative research to guide the development of such an intervention incorporating the latest advances in diabetes science: 1) continuous glucose monitors; 2) teleconsultation; 3) peer group MVPA classes; and 4) context-aware diabetes self-management coaching algorithms. The study represents stage #0 (basic science) of the NIH Stage Model for Behavioral Intervention Development. Specifically, the investigators will conduct a longitudinal, observational study in people with T1D who receive a 10-week mobile intervention that incorporates biosensor feedback, teleconsultation, and online group PA classes. Participants will be followed for 10 weeks to evaluate intervention acceptability and identify potential mechanisms of PA behavior change. The expected outcome of this study is preliminary data for the investigators' future direction of an NIH Small Business Technology Transfer grant application to refine this intervention (NIH Stage Model Stage 1). Specifically, the investigators will utilize the most popular components from the observational study and also develop an algorithm that uses identified predictors of PA to advise patients on timing and preparation for PA. This refined intervention will be pilot tested, then optimized and tested for efficacy using an advanced trial design (such as multiphase optimization strategy) among a larger sample (NIH Stage Model Stage 2).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type1diabetes

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Mobile application
Intervention Description
Mobile application that incorporates biosensor feedback, teleconsultation, and online group physical activity classes
Primary Outcome Measure Information:
Title
Moderate to vigorous physical activity (objective)
Description
Minutes per day assessed by hip accelerometry
Time Frame
10 weeks
Title
Moderate to vigorous physical activity (subjective)
Description
Minutes per day assessed by workouts logged on mobile application
Time Frame
10 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 1 diabetes or other insulin deficiency diabetes a. Diagnosed for at least six months Lower than recommended physical activity level for at least 2 months a. Defined as performing sustained moderate to vigorous physical activity (20min) on less than three days per week Own a smartphone Own a continuous glucose monitor with enough supplies for 10 weeks a. When available, we will provide these to those who do not own them, in which case they will be considered to meet this criteria Exclusion criteria: Chronic renal failure Class 3 obesity a. Defined as body mass index greater than 40 kg/m^2 Pregnancy Cognitive impairment Inability to read and/or understand English Severe retinopathy Neuropathy or nephropathy History of arrhythmia Myocardial infarction and (or) angina in past six months Other chronic disease or physical disability that would influence treatment intervention Other chronic disease or physical disability that would preclude participation in regular physical activity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Garrett Ash, PhD
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale University
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06511
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
34047700
Citation
Ash GI, Griggs S, Nally LM, Stults-Kolehmainen M, Jeon S, Brandt C, Gulanski BI, Spanakis EK, Baker JS, Whittemore R, Weinzimer SA, Fucito LM. Evaluation of Web-Based and In-Person Methods to Recruit Adults With Type 1 Diabetes for a Mobile Exercise Intervention: Prospective Observational Study. JMIR Diabetes. 2021 Jul 8;6(3):e28309. doi: 10.2196/28309.
Results Reference
result
Citation
Ash, G. I., Nally, L. M., Stults-Kolehmainen1, M. A., De-Los-Santos, M., Jeon, S., Brandt, C., Fucito, L. (2021, April 1). Personalized Big Data for Type 1 Diabetes Exercise Support. https://doi.org/10.31236/osf.io/34vdc
Results Reference
result
Links:
URL
https://preprints.jmir.org/preprint/28309
Description
Evaluation of Web-Based and In-Person Methods to Recruit Adults with Type 1 Diabetes for a Technology-Based Exercise Intervention: Prospective Observational Study
URL
https://osf.io/preprints/sportrxiv/34vdc/
Description
Personalized Big Data for Type 1 Diabetes Exercise Support

Learn more about this trial

Mobile Physical Activity for Type 1 Diabetes

We'll reach out to this number within 24 hrs